The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

Checkpoint immunotherapy that targets inhibitory receptors of T cells, thereby reversing the functional exhaustion of T cells, marks a breakthrough in anticancer therapy. The success of T cell-directed checkpoint inhibitors of CTLA-4 and PD-1/PD-L1 has opened a new approach for cancer immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Haoyu, Sun, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812684/
https://www.ncbi.nlm.nih.gov/pubmed/31681269
http://dx.doi.org/10.3389/fimmu.2019.02354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812684/
https://www.ncbi.nlm.nih.gov/pubmed/31681269
http://dx.doi.org/10.3389/fimmu.2019.02354

Ejemplares similares